Evaluating Productivity

Thomas J. Phelan states in his Oct. 2 Opinion1 that peer review has no alternatives for single research product quality evaluation, but publication and citation alternatives may exist for evaluating aggregated research quality. I have examined and developed myriad research evaluation methodologies for some time,2, 3 both for single and aggregate research units. For research evaluations that will impact real-world decisions, peer review is required at all levels of aggregation.2 Publications, pa

Written byRonald Kostoff
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Thomas J. Phelan states in his Oct. 2 Opinion1 that peer review has no alternatives for single research product quality evaluation, but publication and citation alternatives may exist for evaluating aggregated research quality. I have examined and developed myriad research evaluation methodologies for some time,2, 3 both for single and aggregate research units. For research evaluations that will impact real-world decisions, peer review is required at all levels of aggregation.2 Publications, patents, citations, and other output (and outcome) metrics, and even the more detailed retrospective studies, can supplement peer review usefully, but do not replace peer review.

The real problem in evaluating research productivity and impact at any level of aggregation (individual, research unit, agency or company, nation) is that shortcuts in the conduct and analysis of these evaluations are often substituted for the intensive detailed labor required for high-quality results. In many real-world cases, there is little motivation to ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies